Connect with us

Hi, what are you looking for?

American Stock ReviewAmerican Stock Review

Tech News

L’Oréal’s new skincare gadget told me I should try retinol

The Cell BioPrint is designed to be used in retail spaces and dermatology offices. | Photo by Victoria Song / The Verge

Las Vegas is punishingly dry. The arid winter air means I woke up on Day 3 of CES 2025 with a nosebleed, chapped lips, and ashy legs. This in spite of the fact I slathered myself with two pumps of a fermented bean essence, eye cream, moisturizer, and a lip mask. Staring at my face in the hotel mirror, I wonder if any of those products were doing what they’re supposed to — and if maybe, I should try something different.

This is why I was so eager to try L’Oréal’s Cell BioPrint.

For anyone who’s struggled with their complexion, the Cell BioPrint feels like a holy grail gadget. The device is a mini-lab setup that analyzes a skin sample to generate a report about your skin’s current condition. It’ll also “grade” your skin with regard to oiliness, wrinkles, skin barrier function, pore size, and uneven skin tone. Based on the proteins in your skin, you’ll also see whether you’re more likely to be susceptible to those issues down the line — even if they aren’t issues now. The test also determines whether you’re responsive to retinol, a popular and well-studied skincare ingredient that nevertheless causes a ton of confusion online.

Photo by Victoria Song / The Verge

Read the full story at The Verge.

You May Also Like

Tech News

Sony’s “cosmic red” DualSense Wireless Controller is down to $54.99 ($20 off) for a limited time. | Photo by Cameron Faulkner / The Verge...

Tech News

This meat-handed mess was generated using DaVinci AI with the prompt “a photorealistic person looking at their phone with a disgusted expression.” | Image:...

Tech News

Image: Apple Wolfs director Jon Watts told Collider on Friday that he didn’t think a sequel to the George Clooney and Brad Pitt movie,...

Tech News

Image: Netflix After years of brand tie-ins and ill-conceived spinoffs, the series is back — and it’s just as tense as ever. Read the...